Oncology Archives - Page 21 of 22

Post-gemcitabine therapy for patients with advanced pancreatic cancer – a comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens.

Authors: A Vogel, F Ciardiello, R A Hubner, J F Blanc, A Carrato, Y Yang, D A Patel, V Ektare, F A de Jong, S Gill Published: Cancer Treatment Reviews, 2016 View...

Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis

Authors: A Hussain, A Aly, C Daniel Mullins, Y Qian, J Arellano, E Onukwugha Published: Cancer medicine, 2016 View publication Abstract The purpose of this study was to estimate the risk of...

Budgetary impact of cabazitaxel use after docetaxel treatment for metastatic castration-resistant prostate cancer

Authors: K Flannery, E Drea, L Hudspeth, S Corman, X Gao, M Xue, R Miao Published: Journal of managed care & specialty pharmacy, 2017 View publication Background The headroom method was introduced...

Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis

Authors: U Pelzer, JF Blanc, D Melisi, A Cubillo, D D Von Hoff, A Wang-Gillam, L T Chen, J T Siveke, Y Wan, C T Solem, M F Botteman, Y Yang, F...

Psychometric evaluation of the Chinese breast cancer prevention trial symptom scale

Authors: C F Tsai, P S Tsai, C L Liu, Y K Lin, Y L Ling, I J Tseng, Y M Liao Published: Cancer nursing, 2017 View publication Background Women with breast...

The importance of economic perspective and quantitative approaches in oncology value frameworks of drug selection and shared decision making

Authors: A R Waldeck, M F Botteman, R E White, B A van Hout Published: Journal of managed care & specialty pharmacy, 2017 View publication Abstract The debate around value in oncology...

The cost of oropharyngeal cancer in England: a retrospective hospital data analysis

Authors: S T Keeping, M J Tempest, S J Stephens, S M Carroll, R Simcock, T M Jones, R Shaw Published: Clinical otolaryngology and allied sciences, 2018 View publication Objectives To estimate...

Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients

Authors: S Jiang, K Hill, D Patel, A R Waldeck, M Botteman, A Aly, A D Norden Published: Journal of medical economics, 2017 View publication Aim This analysis assessed the direct medical...

Real-world effectiveness of brentuximab vedotin versus physicians’ choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany

Authors: E A Zagadailov, S Corman, V Chirikov, C Johnson, C Macahilig, B Seal, MR Dalal, P J Brockelmann, T Llidge Published: Leukemia & Lymphoma, 2017 View publication Abstract This retrospective study...

News